182 related articles for article (PubMed ID: 15583446)
1. The ecarin clotting time, a universal method to quantify direct thrombin inhibitors.
Nowak G
Pathophysiol Haemost Thromb; 2003 Jul-2004 Aug; 33(4):173-83. PubMed ID: 15583446
[TBL] [Abstract][Full Text] [Related]
2. Modified plasma-based ecarin clotting time assay for monitoring of recombinant hirudin during cardiac surgery.
Choi TS; Khan AI; Greilich PE; Kroll MH
Am J Clin Pathol; 2006 Feb; 125(2):290-5. PubMed ID: 16393689
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assay.
Pötzsch B; Hund S; Madlener K; Unkrig C; Müller-Berghaus G
Thromb Res; 1997 Jun; 86(5):373-83. PubMed ID: 9211628
[TBL] [Abstract][Full Text] [Related]
4. Ecarin clotting time but not aPTT correlates with PEG-hirudin plasma activity.
Moser M; Ruef J; Peter K; Kohler B; Gulba DC; Paterna N; Nordt T; Kübler W; Bode C
J Thromb Thrombolysis; 2001 Oct; 12(2):165-9. PubMed ID: 11729368
[TBL] [Abstract][Full Text] [Related]
5. Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration.
Casserly IP; Kereiakes DJ; Gray WA; Gibson PH; Lauer MA; Reginelli JP; Moliterno DJ
Thromb Res; 2004; 113(2):115-21. PubMed ID: 15115666
[TBL] [Abstract][Full Text] [Related]
6. Ecarin-Based Methods for Measuring Thrombin Inhibitors.
Gosselin RC
Methods Mol Biol; 2023; 2663():355-367. PubMed ID: 37204723
[TBL] [Abstract][Full Text] [Related]
7. Clinical monitoring of hirudin and direct thrombin inhibitors.
Nowak G
Semin Thromb Hemost; 2001 Oct; 27(5):537-41. PubMed ID: 11668425
[TBL] [Abstract][Full Text] [Related]
8. [Follow-up of the treatment by direct thrombin inhibitors: activated partial thromboplastin time or ecarin clotting time].
Kher A; Gouin I; Samama MM
Ann Biol Clin (Paris); 2000; 58(5):575-9. PubMed ID: 11022100
[TBL] [Abstract][Full Text] [Related]
9. Ecarin clotting time is sensitive to heparinoids: comparison of two different techniques.
Demir M; Iqbal O; Untch B; Hoppensteadt DA; Gaikwad BS; Fareed J
Clin Appl Thromb Hemost; 2001 Jan; 7(1):38-43. PubMed ID: 11190903
[TBL] [Abstract][Full Text] [Related]
10. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
Devignes J; de Maistre E; Grosjean S; Walter AF; Hacquard M; Mulot A; Longrois D; Carteaux JP; Lecompte T
Ann Biol Clin (Paris); 2005; 63(2):201-8. PubMed ID: 15771978
[TBL] [Abstract][Full Text] [Related]
11. Hirudin determination in plasma can be strongly influenced by the prothrombin level.
Lindhoff-Last E; Piechottka GP; Rabe F; Bauersachs R
Thromb Res; 2000 Oct; 100(1):55-60. PubMed ID: 11053617
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three methods for measuring PEG-hirudin in blood.
Hoffmann JJ; Janssen WC
Blood Coagul Fibrinolysis; 2001 Oct; 12(7):577-81. PubMed ID: 11685047
[TBL] [Abstract][Full Text] [Related]
13. Ecarin chromogenic assay--a new method for quantitative determination of direct thrombin inhibitors like hirudin.
Lange U; Nowak G; Bucha E
Pathophysiol Haemost Thromb; 2003 Jul-2004 Aug; 33(4):184-91. PubMed ID: 15583447
[TBL] [Abstract][Full Text] [Related]
14. Quantitative determination of hirudin in blood and body fluids.
Nowak G; Bucha E
Semin Thromb Hemost; 1996; 22(2):197-202. PubMed ID: 8807717
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of anticoagulant effects of direct thrombin inhibitors.
Fenyvesi T; Jörg I; Harenberg J
Semin Thromb Hemost; 2002 Aug; 28(4):361-8. PubMed ID: 12244483
[TBL] [Abstract][Full Text] [Related]
16. [Ecarin chromogenic assay: an innovative test for quantitative determination of direct thrombin inhibitors in plasma].
Lange U; Olschewski A; Nowak G; Bucha E
Hamostaseologie; 2005 Aug; 25(3):293-300. PubMed ID: 16113754
[TBL] [Abstract][Full Text] [Related]
17. Microfluidic Point-of-Care Ecarin-Based Clotting and Chromogenic Assays for Monitoring Direct Thrombin Inhibitors.
Alouidor B; Sweeney RE; Tat T; Wong RK; Yoon JY
J Extra Corpor Technol; 2019 Mar; 51(1):29-37. PubMed ID: 30936586
[TBL] [Abstract][Full Text] [Related]
18. A functional clotting assay to monitor the hirudin dosage.
Zakir RM; Hoffman W; Bhatt BA; Spillert CR
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):119-23. PubMed ID: 17287627
[TBL] [Abstract][Full Text] [Related]
19. Comparative anticoagulant effects of various thrombin inhibitors, as determined in the ecarin clotting time method.
Callas DD; Fareed J
Thromb Res; 1996 Sep; 83(6):463-8. PubMed ID: 8885140
[No Abstract] [Full Text] [Related]
20. Methods for the monitoring of direct thrombin inhibitors.
Hafner G; Roser M; Nauck M
Semin Thromb Hemost; 2002 Oct; 28(5):425-30. PubMed ID: 12420237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]